Seeking Alpha
 

Henry Schein, Inc. (HSIC)

- NASDAQ
  • Fri, Mar. 13, 6:05 PM
  • Mon, Mar. 2, 9:44 AM
  • Thu, Feb. 26, 8:12 AM
  • Jun. 17, 2013, 11:11 AM
    Align Technology (ALGN +3.2%) moves up this morning after Stifel Nicolaus' Jonathan Block tweaks his price target up to $40 from $38 and suggests taking advantage of recent volatility to buy the stock. Block says there are number of catalysts to drive the shares higher over the near term, including overly conservative FY14 earnings estimates, resolution of its patent litigation against ClearCorrect, and synergy from its alliance with Henry Schein (HSIC).
    | Comment!
  • Apr. 19, 2013, 3:18 PM
    Henry Schein (HSIC +1.4%) says it's locked in a facility agreement of up to $300M with The Bank of Tokyo-Mitsubishi UFJ based on the securitization of its accounts receivable. The company plans to use the new facility for funding new potential acquisitions, as well as for capital expenditures, the repurchase of the company's capital stock and permitted refinancing of existing debt.
    | Comment!
  • Nov. 1, 2011, 12:28 PM
    Henry Schein (HSIC -7.4%) beat Q3 estimates, but earnings climbed less-than-expected as the vaccine maker suffered from lower sales of its flu shots and margin pressure due to higher costs. The company also issues cautious guidance for FY12, citing foreign currency concerns.
    | Comment!
Visit Seeking Alpha's
HSIC vs. ETF Alternatives
Company Description
Henry Schein Inc is engaged in providing health care products and services to office-based dental, animal health and medical practitioners. It also provides its services to government, institutional health care clinics and other alternate care clinics.